Bond Screener
.png){kind=logo}
Merck & Co
LEI 4YV9Y5M8S0BRK1RP0397, SWIFT MEKCUS3WXXX
Organization name
Merck&Co Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
53,322 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
|
General information
-
Organization nameMerck&Co Inc
-
Organization statusOperating organization
-
Address126 East Lincoln Avenue, Rahway, USA, 07065-1310
-
Site
-
IR Site
News
-
Merck (MRK) Reports Q2 Loss, Beats Revenue Estimates04/08/2026
-
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline04/08/2026
-
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 401/07/2026
-
The Zacks Analyst Blog Highlights Merck, The Southern, Lumentum and Peoples Bancorp of North Carolina11/06/2026
-
New issues: Merck & Co issued international bonds (US58933YCF07, US58933YCG89, US58933YCH62, US58933YCJ29) in the amount of USD 1000, USD 1500, USD 500, USD 1000 mln maturing in 2033, 2036, 2046, 2056 respectively.20/05/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameMerck&Co Inc
-
Organization statusOperating organization
-
Address126 East Lincoln Avenue, Rahway, USA, 07065-1310
-
Site
-
IR Site
Codes
-
LEI4YV9Y5M8S0BRK1RP0397
-
SWIFTMEKCUS3WXXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000310158
-
EIN22-1918501
